Nicolas Chevalier

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Benign Prostatic Hyperplasia

Breast Cancer Cells

Top Venues

International journal of molecular sciences

Diabetes, obesity & metabolism

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Quentin A Serrano, Sébastien Le Garf, Vincent Martin, Serge S Colson, Nicolas Chevalier
Is Physical Activity an Efficient Strategy to Control the Adverse Effects of Persistent Organic Pollutants in the Context of Obesity? A Narrative Review. International journal of molecular sciences 25 (2) (2024)
Quentin A Serrano, Sébastien Le Garf, Vincent Martin, Serge S Colson, Nicolas Chevalier
Is Physical Activity an Efficient Strategy to Control the Adverse Effects of Persistent Organic Pollutants in the Context of Obesity? A Narrative Review. International journal of molecular sciences 25 (2) (2024)
Elsa Toumi, Fabien Almairac, Lydiane Mondot, Albert Themelin, Anne-Gaëlle Decoux-Poullot, Philippe Paquis, Nicolas Chevalier, Stephanie Baillif, Sacha Nahon-Estève, Arnaud Martel
Benefit of Optical Coherence Tomography-Angiography in Patients Undergoing Transsphenoidal Pituitary Adenoma Surgery: A Prospective Controlled Study. Diagnostics (Basel, Switzerland) 14 (16) (2024)
Quentin A Serrano, Sébastien Le Garf, Vincent Martin, Serge S Colson, Nicolas Chevalier
Is Physical Activity an Efficient Strategy to Control the Adverse Effects of Persistent Organic Pollutants in the Context of Obesity? A Narrative Review. International journal of molecular sciences 25 (2) (2024)
Charlotte Hinault, Philippe Caroli-Bosc, Frederic Bost, Nicolas Chevalier
Critical Overview on Endocrine Disruptors in Diabetes Mellitus. International journal of molecular sciences 24 (5) (2023)
Charlotte Hinault, Philippe Caroli-Bosc, Frederic Bost, Nicolas Chevalier
Critical Overview on Endocrine Disruptors in Diabetes Mellitus. International journal of molecular sciences 24 (5) (2023)
Charlotte Hinault, Philippe Caroli-Bosc, Frederic Bost, Nicolas Chevalier
Critical Overview on Endocrine Disruptors in Diabetes Mellitus. International journal of molecular sciences 24 (5) (2023)
Aurélie Charazac, Charlotte Hinault, Bastien Dolfi, Solène Hautier, Célia Decondé Le Butor, Frederic Bost, Nicolas Chevalier
Low Doses of PFOA Promote Prostate and Breast Cancer Cells Growth through Different Pathways. International journal of molecular sciences 23 (14) (2022)
Matthieu Wargny, Louis Potier, Pierre Gourdy, Matthieu Pichelin, Coralie Amadou, Pierre-Yves Benhamou, Jean-Baptiste Bonnet, Lyse Bordier, Olivier Bourron, Claude Chaumeil, Nicolas Chevalier, Patrice Darmon, Blandine Delenne, Delphine Demarsy, Marie Dumas, Olivier Dupuy, Anna Flaus-Furmaniuk, Jean-François Gautier, Anne-Marie Guedj, Nathalie Jeandidier, Etienne Larger, Jean-Philippe Le Berre, Myriam Lungo, Nathanaëlle Montanier, Philippe Moulin, Françoise Plat, Vincent Rigalleau, Rene Robert, Dominique Seret-Bégué, Pierre Sérusclat, Sarra Smati, Jean-François Thébaut, Blandine Tramunt, Camille Vatier, Fritz-Line Velayoudom, Bruno Vergès, Patrice Winiszewski, Audrey Zabulon, Pierre-Antoine Gourraud, Ronan Roussel, Bertrand Cariou, Samy Hadjadj, null null
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia 64 (4) (2021)
Ronan Roussel, Patrice Darmon, Matthieu Pichelin, Thomas Goronflot, Yawa Abouleka, Leila Ait Bachir, Ingrid Allix, Abdallah Al-Salameh, Sophie Borot, Lyse Bordier, Aurélie Carlier, Nicolas Chevalier, Christine Coffin-Boutreux, Emmanuel Cosson, Anne Dorange, Olivier Dupuy, Pierre Fontaine, Bénédicte Fremy, Florence Galtier, Natacha Germain, Anne-Marie Guedj, Etienne Larger, Stéphanie Laugier-Robiolle, Bruno Laviolle, Lisa Ludwig, Arnaud Monier, Nathanaëlle Montanier, Philippe Moulin, Isabelle Moura, Gaëtan Prevost, Yves Reznik, Nadia Sabbah, Pierre-Jean Saulnier, Pierre Serusclat, Camille Vatier, Matthieu Wargny, Samy Hadjadj, Pierre Gourdy, Bertrand Cariou, null null
Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study. Diabetes, obesity & metabolism 23 (5) (2021)